Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blazer

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
The Lancet. Rheumatology|June 2, 2021
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohortAmit Saxena, Allison Guttmann, Mala Masson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2020
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus ErythematosusRuth Fernandez-Ruiz, Mala Masson, Mimi Y Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 VaccinationPeter M Izmirly, Mimi Y Kim, Marie Samanovic, et al.
European Journal of Epidemiology|September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, J Danesh, S Erqou, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
The Lancet. Rheumatology|June 2, 2021
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohortAmit Saxena, Allison Guttmann, Mala Masson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2020
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus ErythematosusRuth Fernandez-Ruiz, Mala Masson, Mimi Y Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 VaccinationPeter M Izmirly, Mimi Y Kim, Marie Samanovic, et al.
European Journal of Epidemiology|September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, J Danesh, S Erqou, et al.
Pageof 9